Drug Profile
NCT 101
Alternative Names: NCT-101Latest Information Update: 11 Sep 2023
Price :
$50
*
At a glance
- Originator Novacell Technology
- Class Antineoplastics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 11 Sep 2023 Discontinued - Preclinical for Breast cancer in China (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Breast-cancer in China
- 20 Jul 2016 Preclinical trials in Breast cancer in China (unspecified route)